BridgeBio Oncology Therapeutics logo
BridgeBio Oncology Therapeutics
BBOT | NASDAQ
Chart Builder DCF Calculator
$1.98
-$0.16 (-7.48%)
At close: Nov 16, 2026, 4:00 PM ET
$2.01
+$0.03 (+1.52%)
After-hours: Nov 16, 2026, 7:00 PM ET

BridgeBio Oncology Therapeutics Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
– – – – –
– – – – –
– – – – –
-145.82M -80.86M -64.77M -3.52K -43.36K
11.34M 6.38M 72K – –
-134.04M -74.28M -64.7M -3.52K -43.36K
-134.04M -74.28M -64.7M -3.52K -43.36K
24.62M 7.76M 8.49M 3.52K 43.36K
121.2M 73.11M 56.29M – –
– – – – –
145.82M 80.86M 64.77M 3.52K 43.36K
– – – – –
– – – – –
145.82M 80.86M 64.77M 3.52K 43.36K
– – – – –
31.14M 12.9K 20.49M 20.49M 20.49M
31.14M 12.9K 20.49M 20.49M 20.49M
-4.30 -5.76K 0 – 0
-4.30 -5.76K -3.16 0 0
-145.21M -80.66M -64.68M – -43.36K
-145.82M -80.86M -64.77M -3.52K -43.36K
610K 208K 92K 3.52K –

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.